Form EFFECT Galera Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 7, 2026 |
| Accession Number: | 0001193125-26-332796 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HelloNation Explains Is Sedation Dentistry Safe for Kids Featuring Pediatric Dentistry Expert Dr. Andrew Beuttenmuller
- Independent MUSC Research Demonstrates Enterprise Value of AI-Native Virtual Nursing Powered by ThinkAndor®
- Bradford Health Services Enters New Phase of Growth, Names Justin Adams Chief Operating Officer and Adds John Hollinsworth to Board
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
